International Clinical Trial: Prospective study protocol for predicting clinical cure of CHB with PegIFNa-2b based on baseline and early treatment peripheral blood CD4+PD-1+ and CD8+PD-1+ T cell levels

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118395) titled 'Prospective study protocol for predicting clinical cure of CHB with PegIFNa-2b based on baseline and early treatment peripheral blood CD4+PD-1+ and CD8+PD-1+ T cell levels' on Feb. 4.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: West China Hospital, Sichuan University

Condition: Chronic hepatitis B

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-07-30

Target Sample Size: PegIFN treatment group:300;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=280672

Published by HT Digital Content Services wit...